Page last updated: 2024-09-02

perindopril and Alloxan Diabetes

perindopril has been researched along with Alloxan Diabetes in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (23.40)18.2507
2000's25 (53.19)29.6817
2010's11 (23.40)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baranska, M; Buczek, E; Chlopicki, S; Fedorowicz, A; Malek, K; Mateuszuk, L; Staniszewska-Slezak, E; Wiercigroch, E1
Annaratone, L; Barutta, F; Bellini, S; Bruno, G; Corbetta, B; di Marzo, V; Gambino, R; Gruden, G; Makriyannis, A; Mastrocola, R; Piscitelli, F; Vemuri, VK1
Jakjovski, K; Labacevski, N; Petrusevska, G; Trojacanec, J; Trojacanec, P; Zafirov, D; Zdravkovski, P1
Bhadada, SV; Patel, BM1
Başar, M; Ertürküner, SP; Seçkin, İ; Tunçdemir, M1
Öztürk, M; Tunçdemir, M1
Gilbert, RE; Kelly, DJ; Langham, RG; Tiauw, V; Wiggins, KJ; Zhang, Y1
Gao, L; Yu, DM1
Cho, CS; Kim, JH; Kim, KW; Yu, YS1
Chen, H; Fan, Y; Gu, Q; Ho, PC; Ke, G; Sun, X; Xu, X; Zheng, Z; Zou, H1
Cheng, XY; Ge, N; Li, SM; Li, YY; Lu, JD; Shao, MM; Sun, HL; Sun, L1
Cheng, S; Li, H; Li, J; Li, X; Qi, C; Xu, G; Yuan, L1
Li, X; Qi, CJ; Xu, GL; Yuan, L1
Hu, F; Liu, L; Shu, XC; Sun, HL; Sun, L; Sun, Y; Wen, JH; Yang, Q; Yin, DC; Zeng, YJ1
Chan, JS; Chenier, I; Filep, JG; Godin, N; Ingelfinger, JR; Liu, F; Lo, CS; Maachi, H; Shi, Y; Zhang, SL1
Agarwal, SS; Bhadada, SV; Patel, BM1
Ahola, A; Cooper, ME; Forsblom, C; Gordin, D; Groop, PH; Harjutsalo, V; Moran, J; Pickering, RJ; Saraheimo, M; Thomas, MC; Thorn, L; Tikellis, C; Tolonen, N; Tsorotes, D; Wadén, J1
Chen, X; Liu, SK; You, JL; Zhou, M1
Wu, XY; Zhong, HJ; Zhou, M1
Armitage, JA; Bui, BV; Cooper, ME; Tolcos, M; Vingrys, AJ1
Allen, TJ; Burns, WC; Burrell, LM; Cao, Z; Cooper, ME; Davis, BJ; Johnston, CI; Kubota, E1
Burns, WC; Cooper, ME; Tikellis, C; Tolcos, M; Twigg, SM1
Allen, TJ; Burns, WC; Cooper, ME; Davis, BJ; Forbes, JM; Jerums, G; Kawachi, H; Thomas, MC1
Gilbert, RE; Kelly, DJ; Koji, T; Maguire, J; Stein-Oakley, A; Thomson, N; Wassef, L; Wilkinson-Berka, JL; Zhang, Y1
Biswas, SK; de Faria, JB; de Faria, JM1
Erensoy, N; Hatemi, H; Oztürk, M; Tunçdemir, M; Uysal, O; Yilmazer, S1
Damgé, C; Daussin, F; Geny, B; Helms, P; Piquard, F; Rasseneur, L; Rouyer, O; Talha, S; Zoll, J1
Brezniceanu, ML; Chan, JS; Chénier, I; Filep, JG; Ingelfinger, JR; Liu, F; Sachetelli, S; Wei, CC; Zhang, SL1
Bialkowski, K; Cooper, ME; Johnston, C; Pete, J; Sheehy, K; Su, Q; Thomas, MC; Tikellis, C1
Cohen, R; Emonnot, L; Lo, M1
Cooper, ME; Doyle, AE; Rumble, JR1
Chou, ST; Cooper, ME; Du, HC; Jandeleit, K; Komers, R; Rumble, J1
Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC1
Cooper, M; Gin, T; Jerums, G; Joon, TL; Panagiotopoulos, S; Taylor, H1
Charlesworth, JA; Duggan, KA; Hodge, G; Makarious, MM2
Liu, Y; Lu, J; Pan, C1
Allen, TJ; Cao, Z; Cooper, ME; Gilbert, RE; Jandeleit, K; Rumble, JR1
Cheng, H; Fu, Z; Yan, L; Yan, T; Yang, R; Zhong, G1
Cooper, ME; Cox, AJ; Gilbert, RE; Hendrich, EC; Jerums, G; Kelly, DJ; Lee, V; Osicka, T; Panagiotopoulos, S; Rumble, JR; Wilkinson-Berka, JL1
Cooper, ME; Gibbs, NJ; Kelly, DJ; Skinner, SL; Wilkinson-Berka, JL1
Cooper, ME; Cox, AJ; Gilbert, RE; Kelly, DJ; Tolcos, M; Wilkinson-Berka, JL1
Cox, AJ; Gilbert, RE; Kelly, DJ; Ricardo, SD; Wilkinson-Berka, JL1
Allen, TJ; Burns, WC; Candido, R; Cao, Z; Cooper, ME; Dilley, RJ; Jandeleit-Dahm, KA; Nesteroff, SP; Twigg, SM1
Aaltonen, P; Cox, AJ; Gilbert, RE; Holthöfer, H; Jerums, G; Kelly, DJ; Langham, R; Panagiotopoulos, S; Rumble, JR1
Cooper, ME; Gin, T; Lim-Joon, T; Rumble, JR1
Allen, TJ; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Rumble, JR1

Other Studies

47 other study(ies) available for perindopril and Alloxan Diabetes

ArticleYear
A possible Fourier transform infrared-based plasma fingerprint of angiotensin-converting enzyme inhibitor-induced reversal of endothelial dysfunction in diabetic mice.
    Journal of biophotonics, 2018, Volume: 11, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Chemical Analysis; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium; Mice; Perindopril; Spectroscopy, Fourier Transform Infrared

2018
Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.
    British journal of pharmacology, 2018, Volume: 175, Issue:23

    Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Mice; Mice, Inbred C57BL; Morpholines; Perindopril; Pyrazoles; Receptor, Cannabinoid, CB1

2018
Perindopril treatment in streptozotocin induced diabetic nephropaty.
    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2013, Volume: 34, Issue:1

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerulonephritis; Hypertrophy; Kidney; Male; Perindopril; Rats, Wistar; Streptozocin; Time Factors

2013
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:5

    Topics: Animals; Animals, Newborn; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Metoprolol; Perindopril; Ramipril; Rats, Wistar; Spironolactone

2014
The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:2

    Topics: Albuminuria; Animals; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Mesangium; Male; Microscopy, Electron; Perindopril; Podocytes; Rats; Rats, Wistar; Streptozocin; Transforming Growth Factor beta1

2014
Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
    Metabolism: clinical and experimental, 2016, Volume: 65, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Biphenyl Compounds; Blood Glucose; Caspase 3; Cytochromes c; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Irbesartan; Kidney; Kidney Glomerulus; Kidney Tubules; Ku Autoantigen; Male; Perindopril; Rats; Rats, Wistar; Tetrazoles

2016
Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.
    Nephrology (Carlton, Vic.), 2008, Volume: 13, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Fibrosis; Hypoxia; Immunohistochemistry; Inflammation; Kidney Tubules; Macrophages; Nitroimidazoles; Osteopontin; Perindopril; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors

2008
Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Chinese medical journal, 2008, Nov-05, Volume: 121, Issue:21

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Extremities; Fibroblast Growth Factor 2; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Vascular Endothelial Growth Factor A

2008
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Retinal Barrier; Capillary Permeability; Cell Line; Dextrans; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Fluoresceins; Humans; Mice; Mice, Inbred C57BL; Perindopril; Retina; Tight Junctions; Vascular Endothelial Growth Factor A

2009
Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway.
    Diabetes, 2009, Volume: 58, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cattle; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Eye Proteins; Glucose; Male; Membrane Potentials; Mitochondria; Mitochondrial Membranes; Nerve Growth Factors; Perindopril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Survivors; Vascular Endothelial Growth Factor A

2009
ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, Volume: 117, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; eIF-2 Kinase; Endoplasmic Reticulum; Heat-Shock Proteins; Kidney Tubules; Male; Molecular Chaperones; Perindopril; Rats; Rats, Sprague-Dawley; Streptozocin; Stress, Physiological

2009
Effect of renin angiotensin system blockade on the islet microvessel density of diabetic rats and its relationship with islet function.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2009, Volume: 29, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Microvessels; Perindopril; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2009
Effects of renin-angiotensin system blockade on islet function in diabetic rats.
    Journal of endocrinological investigation, 2010, Volume: 33, Issue:1

    Topics: Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Glucose Tolerance Test; In Situ Nick-End Labeling; Islets of Langerhans; Male; Nitric Oxide Synthase Type II; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan

2010
Perindopril attenuates renal tubulointerstitium injury by inhibiting scavenger receptor A over-expression in diabetic rats.
    Journal of endocrinological investigation, 2012, Volume: 35, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Disease Models, Animal; Immunoenzyme Techniques; Kidney Tubules; Macrophages; Male; Perindopril; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scavenger Receptors, Class A

2012
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
    American journal of physiology. Renal physiology, 2012, Apr-01, Volume: 302, Issue:7

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Hypertension; Kidney; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nephrosclerosis; Peptidyl-Dipeptidase A; Perindopril; Rats; Renin-Angiotensin System; Transgenes

2012
Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations.
    Human & experimental toxicology, 2012, Volume: 31, Issue:11

    Topics: Animals; Animals, Newborn; Blood Glucose; Cardiomegaly; Cardiotonic Agents; Diabetes Mellitus, Experimental; Female; Glutathione; Hemodynamics; Lipids; Male; Malondialdehyde; Oxidative Stress; Perindopril; Rats; Rats, Wistar

2012
Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes.
    Clinical science (London, England : 1979), 2013, Volume: 124, Issue:10

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Atherosclerosis; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diet, Sodium-Restricted; Female; Finland; Humans; Male; Mice; Mice, Knockout; Middle Aged; Perindopril; Plaque, Atherosclerotic; Renin-Angiotensin System; Sodium; Sodium, Dietary

2013
[Protective effect of perindopril on dysfunction of endothelium-dependent relaxation in diabetic rats].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2000, Apr-28, Volume: 25, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Endothelium, Vascular; Male; Perindopril; Rats; Rats, Sprague-Dawley; Vasodilation

2000
[Changes of ultrastructure and function of the aortic endothelium in streptozotocin-diabetic rats and effect of perindopril].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2001, Feb-28, Volume: 26, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium, Vascular; Male; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley

2001
ACE inhibition salvages the visual loss caused by diabetes.
    Diabetologia, 2003, Volume: 46, Issue:3

    Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electroretinography; Guanidines; Perindopril; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Retina; Vision Disorders

2003
Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.
    Diabetologia, 2003, Volume: 46, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension; Immunohistochemistry; Kidney; Male; Membrane Proteins; Peptidyl-Dipeptidase A; Perindopril; Proteins; Rats; Rats, Inbred SHR; Reference Values

2003
Connective tissue growth factor is up-regulated in the diabetic retina: amelioration by angiotensin-converting enzyme inhibition.
    Endocrinology, 2004, Volume: 145, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gene Expression Regulation; Immediate-Early Proteins; Immunohistochemistry; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Male; Perindopril; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution

2004
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
    Diabetologia, 2004, Volume: 47, Issue:1

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Guanidines; Kidney; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Inbred SHR

2004
Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade.
    Nephrology (Carlton, Vic.), 2004, Volume: 9, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fas Ligand Protein; fas Receptor; Female; Membrane Glycoproteins; Perindopril; Rats

2004
Davis BJ, Forbes JM, Thomas MC et al. (2004) Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia 47:89-97.
    Diabetologia, 2004, Volume: 47, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Guanidines; Nitric Oxide Synthase; Perindopril; Rats; Rats, Inbred SHR

2004
Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
    Acta histochemica, 2004, Volume: 106, Issue:4

    Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Basement Membrane; Blood Glucose; Body Weight; Collagen Type IV; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique, Indirect; Kidney Glomerulus; Kidney Tubules; Laminin; Male; Perindopril; Rats; Rats, Wistar

2004
Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
    Experimental physiology, 2007, Volume: 92, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Cell Respiration; Diabetes Mellitus, Experimental; Insulin; Male; Mitochondria, Muscle; Muscle, Skeletal; Perindopril; Physical Conditioning, Animal; Rats; Rats, Wistar; Regional Blood Flow; Streptozocin

2007
Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
    Journal of the American Society of Nephrology : JASN, 2008, Volume: 19, Issue:2

    Topics: Albuminuria; Angiotensinogen; Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blood Glucose; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hydralazine; Hypertension, Renal; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Rats; Renin-Angiotensin System

2008
ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes.
    Diabetes, 2008, Volume: 57, Issue:4

    Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Perindopril

2008
Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
    American journal of hypertension, 2008, Volume: 21, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System

2008
Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    American journal of hypertension, 1995, Volume: 8, Issue:1

    Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Hypertension; Indoles; Kidney Diseases; Male; Perindopril; Random Allocation; Rats; Rats, Inbred SHR; Renin

1995
Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.
    Diabetes, 1994, Volume: 43, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypertrophy; Indoles; Insulin; Male; Muscle, Smooth, Vascular; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Splanchnic Circulation

1994
The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
    Diabetes, 1993, Volume: 42, Issue:4

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerular Mesangium; Hydralazine; Hydrochlorothiazide; Indoles; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Sprague-Dawley; Reserpine

1993
Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Investigative ophthalmology & visual science, 1996, Volume: 37, Issue:2

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dihydropyridines; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Indoles; Kidney; Male; Organ Specificity; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Retina; Serum Albumin

1996
Acute but not chronic angiotensin-converting enzyme inhibition induces enzyme synthesis in the glomerulus of the spontaneously hypertensive rat.
    Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Administration Schedule; Enzyme Induction; Female; Indoles; Kidney Glomerulus; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred SHR

1997
[The influence of perindopril on intrarenal RAS in experimental diabetic rats].
    Zhonghua yi xue za zhi, 1996, Volume: 76, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Diabetes Mellitus, Experimental; Indoles; Kidney; Male; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger

1996
Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
    Clinical science (London, England : 1979), 1998, Volume: 94, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Indoles; Kidney Glomerulus; Peptidyl-Dipeptidase A; Perindopril; Proteins; Random Allocation; Rats; Rats, Inbred SHR

1998
Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies.
    Metabolism: clinical and experimental, 1998, Volume: 47, Issue:12 Suppl 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypertrophy; Indoles; Male; Perindopril; Rats; Rats, Sprague-Dawley; RNA, Messenger; Splanchnic Circulation; Transforming Growth Factor beta

1998
Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
    Chinese medical journal, 1998, Volume: 111, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Indoles; Male; Perindopril; Random Allocation; Rats; Rats, Wistar

1998
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
    Diabetologia, 2000, Volume: 43, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Gene Expression; In Situ Hybridization; Lymphokines; Male; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Female; Heterozygote; Kidney; Perindopril; Rats; Renin; Tetrazoles; Valine; Valsartan

2001
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
    Kidney international, 2002, Volume: 61, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Apoptosis; Atrophy; Autoradiography; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epidermal Growth Factor; Female; Fibrosis; Gene Expression; In Situ Hybridization; In Situ Nick-End Labeling; Kidney Tubules; Nephritis, Interstitial; Perindopril; Rats; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2002
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Female; Humans; Kidney; Kidney Tubules; Macrophages; Osteopontin; Perindopril; Rats; Renin; Sialoglycoproteins; Transcription, Genetic

2002
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
    Circulation, 2002, Jul-09, Volume: 106, Issue:2

    Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Disease Progression; Growth Substances; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Phagocytes; Proliferating Cell Nuclear Antigen; RNA, Messenger; Vascular Cell Adhesion Molecule-1

2002
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA Primers; Guanidines; In Situ Hybridization; Male; Membrane Proteins; Mutation; Perindopril; Proteins; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2002
Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
    Clinical and experimental pharmacology & physiology. Supplement, 1992, Volume: 19

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Dihydropyridines; Hypertension, Renovascular; Indoles; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1992
Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
    Kidney international, 1992, Volume: 41, Issue:4

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Drug Combinations; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Reserpine

1992